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A bacterial ABC transporter 
enables import of mammalian host 
glycosaminoglycans
Sayoko Oiki1, Bunzo Mikami2, Yukie Maruyama3, Kousaku Murata3 & Wataru Hashimoto1
Glycosaminoglycans (GAGs), such as hyaluronan, chondroitin sulfate, and heparin, constitute 
mammalian extracellular matrices. The uronate and amino sugar residues in hyaluronan and 
chondroitin sulfate are linked by 1,3-glycoside bond, while heparin contains 1,4-glycoside bond. Some 
bacteria target GAGs as means of establishing colonization and/or infection, and bacterial degradation 
mechanisms of GAGs have been well characterized. However, little is known about the bacterial import 
of GAGs. Here, we show a GAG import system, comprised of a solute-binding protein (Smon0123)-
dependent ATP-binding cassette (ABC) transporter, in the pathogenic Streptobacillus moniliformis. A 
genetic cluster responsible for depolymerization, degradation, and metabolism of GAGs as well as the 
ABC transporter system was found in the S. moniliformis genome. This bacterium degraded hyaluronan 
and chondroitin sulfate with an expression of the genetic cluster, while heparin repressed the bacterial 
growth. The purified recombinant Smon0123 exhibited an affinity with disaccharides generated from 
hyaluronan and chondroitin sulfate. X-ray crystallography indicated binding mode of Smon0123 to 
GAG disaccharides. The purified recombinant ABC transporter as a tetramer (Smon0121-Smon0122/
Smon0120-Smon0120) reconstructed in liposomes enhanced its ATPase activity in the presence of 
Smon0123 and GAG disaccharides. This is the first report that has molecularly depicted a bacterial 
import system of both sulfated and non-sulfated GAGs.
Extracellular matrices are ubiquitously present in all mammalian tissues and organs and serve as physical scaf-
folds for cellular constituents, cell differentiation, homeostasis, and tissue formation1. Glycosaminoglycans 
(GAGs), major components of extracellular matrices, are acidic heteropolysaccharides with a typical disaccha-
ride (uronate and amino sugar)-repeating unit2. GAGs are classified as hyaluronan, chondroitin sulfate, heparin, 
or heparan sulfate based on constituent sugar, mode of glycoside bond, and sulfation level3. Hyaluronan consists 
of d-glucuronic acid (GlcUA) and N-acetyl-d-glucosamine (GlcNAc), and chondroitin sulfate is comprised of 
GlcUA and N-acetyl-d-galactosamine (GalNAc) with a sulfate group(s) at position 4 or 6 or both. Heparin and 
heparan sulfate are composed of GlcUA or l-iduronic acid (IdoUA) and d-glucosamine (GlcN) or GlcNAc4. 
Residues, uronate and amino sugar, in hyaluronan and chondroitin sulfate are linked by 1,3-glycoside bonds, 
while residues in heparin and heparan sulfate are linked by 1,4-glycoside bonds. With the exception of hyaluro-
nan, these GAGs frequently contain sulfate groups in uronate and/or amino sugar residues.
Some pathogenic bacteria target mammalian GAGs as a means of establishing colonization and/or infection5. 
Particularly, in pathogenic Gram-positive bacteria, such as staphylococci and streptococci, GAGs (e.g., hyalu-
ronan and chondroitin sulfate) are depolymerized to unsaturated disaccharides by extracellular or cell-surface 
polysaccharide lyase (HysA) through a β-elimination reaction6–8 (Fig. 1). Our previous reports indicated that 
resultant unsaturated GAG disaccharides with C=C double bonds at non-reducing termini are degraded to con-
stituent monosaccharides (i.e., unsaturated uronate and amino sugar) by unsaturated glucuronyl hydrolase (UGL) 
through hydration of C=C double bonds in the cytoplasm9, 10. More recently, it was demonstrated that unsatu-
rated uronate is metabolized to pyruvate and glyceraldehyde-3-phosphate by subsequent reactions of isomer-
ase (DhuI), NADH-dependent reductase (DhuD), kinase (KdgK), and aldolase (KdgA)11. In the streptococcal 
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genome, these enzymes (HysA, UGL, DhuI, DhuD, KdgK, and KdgA) are encoded as a GAG genetic cluster, 
which is crucial for depolymerization, degradation, and metabolism of GAGs (Fig. 2A). A putative phosphotrans-
ferase system (PTS), also part of the streptococcal GAG genetic cluster, is expressed in the presence of hyaluro-
nan12, and mutated PTS genes resulted in failed utilization of hyaluronan13, suggesting that the PTS is involved in 
bacterial import of the non-sulfated GAG.
To note, PTS, a sugar transport system specific to bacteria, is composed of Enzyme I (EI), histidine-containing 
phosphocarrier protein (HPr), and Enzyme II (EII) with hetero-subunits (e.g., IIA, IIB, IIC, and IID)14. EI and 
HPr are located in the cytoplasm and non-specifically recognize PTS substrates; EII, which consists of cell mem-
brane and cytoplasmic domains, specifically recognizes PTS substrates. Mechanistically, PTS mediates sugar 
uptake via phosphorylating sugar substrates at the C-6 position through an initial phosphotransfer from phos-
phoenolpyruvate (PEP) and involvement of EI, HPr, and EII15. Because a large number of GAGs, except for 
hyaluronan, are frequently sulfated at the C-6 position16, unsaturated GAG disaccharides sulfated at the C-6 
position may be unsuitable PTS substrates. In fact, more than 20 sugars have been identified to be imported by 
PTS, though no sugars with a modification at C-6 position are included in these substrates17.
In addition, the pathogenic Gram-negative bacterium Streptobacillus moniliformis has a similar GAG genetic 
cluster (Fig. 2B). S. moniliformis usually colonizes the rodent oral cavity and is the causative agent of Rat-bite fever 
in humans either directly or indirectly exposed to rodents18. Rat-bite fever is characterized by polyarthralgia, 
high fever, and headache, and its fatality rate reaches to 10% among untreated patients19. In the Streptobacillus 
GAG genetic cluster, a periplasmic solute-binding protein-dependent ATP-binding cassette (ABC) transporter is 
encoded in place of PTS. Because ABC transporters incorporate substrates into the cytoplasm without any modi-
fications20, we hypothesized that GAGs sulfated at C-6 position should be viable substrates for ABC transporters, 
which is confirmed by this study.
In addition to bacterial depolymerization and degradation of GAGs, investigating the GAG import system is 
important to further elucidate bacterial physiology and pathogenicity. For some bacteria among normal bacte-
rial flora, the GAG import system is required for assimilation of GAG present on host cells. Generally, bacterial 
Figure 1. Bacterial system for degradation and import of GAGs. GAGs such as hyaluronan and chondroitin 
sulfate are depolymerized to unsaturated disaccharides by extracellular or cell-surface polysaccharide lyases. 
The resultant unsaturated disaccharides are incorporated to cytoplasm by PTS or periplasmic binding protein-
dependent ABC transporter. In the case of PTS, substrates (unsaturated disaccharides) are phosphorylated 
across the cytoplasmic membrane. Unsaturated disaccharides are degraded to constituent monosaccharides 
(unsaturated uronate and amino sugar) by UGL, and the resultant unsaturated uronate is metabolized to 
pyruvate and glyceraldehyde-3-phosphate (G-3-P) by subsequent reactions of isomerase, reductase, kinase and 
aldolase. The pathway and proteins/enzymes are detailed in the text. P enclosed in a yellow hexagon, phosphate 
group; S enclosed in a cyan hexagon, sulfate group.
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polysaccharide-degrading enzymes are expressed under the control of cytoplasmic transcriptional regulators that 
sense substrates21, 22. Inhibition of the import system results in reduced expression of these degrading enzymes, 
which may be a means to minimize the brunt of bacterial GAG-dependent infectious diseases. This study aimed 
to identify molecular components of the S. moniliformis GAG import system, structurally determine the GAG 
import proteins that interact and bind to sulfated and non-sulfated GAG disaccharides via X-ray crystallography, 
and functionally characterize the ABC transporter.
Results
Streptobacillus moniliformis GAG genetic cluster. Our previous reports11, 12 indicated the presence of 
a genetic cluster responsible for depolymerization, degradation, and metabolism of GAGs in pathogenic bacteria, 
such as streptococci, enterococci, and clostridia. These bacterial GAG genetic clusters encode polysaccharide 
lyase and UGL. Hyaluronate and heparan sulfate lyases encoded by the cluster are classified in polysaccharide 
lyase (PL) families 8 and 12, respectively, as per the Carbohydrate Active enZyme (CAZy) database23, while all 
UGLs are solely members of the glycoside hydrolase (GH) family 88 according to the database. These depolym-
erizing and degrading enzymes are well conserved among bacterial GAG genetic clusters. In addition to such 
enzymes, genes coding for PTS are frequently observed in the cluster. There are, however, some variations in 
constitutive genes among GAG-related bacteria. For example, isomerases (streptococcal DhuI and clostridial 
KduI) and reductases (streptococcal DhuD and clostridial KduD) function as 4-deoxy-L-threo-5-hexosulose-
uronate ketol-isomerase and 2-keto-3-deoxy-D-gluconate dehydrogenase, respectively, although little homology 
is observed between DhuI and KduI and between DhuD and KduD11. Thus, we decided to investigate GAG cluster 
organization in genome-sequenced bacteria.
Interestingly, the Gram-negative bacterium S. moniliformis24 possessed a similar GAG genetic cluster con-
taining genes which encode for a solute-binding protein-dependent ABC transporter (Fig. 2B). Based on 
the primary structure, the proteins encoded in the genetic cluster were annotated as follows: Smon0115, 
2-dehydro-3-deoxygluconokinase (KdgK); Smon0116, 2-dehydro-3-deoxyphosphogluconate aldolase (KdgA); 
Smon0117, PL family 8 hyaluronate lyase (HysA); Smon0118, 2-deoxy-D-gluconate 3-dehydrogenase (KduD); 
Figure 2. Bacterial GAG genetic clusters. (A) Genetic cluster of Streptococcus agalactiae/Streptococcus 
pneumoniae. (B) Genetic cluster of Streptobacillus moniliformis. Genes for GAG depolymerization, degradation, 
and metabolism, except for import, are well conserved between the two bacterial clusters. Genetic clusters 
of Streptococcus and Streptobacillus encode PTS and the solute-binding protein-dependent ABC transporter, 
respectively, as an importer.
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Smon0119, 4-deoxy-L-threo-5-hexosulose-uronate ketol-isomerase (KduI); Smon0120, multiple sugar transport 
system (ATP-binding protein); Smon0121, putative aldouronate transport system (permease protein); Smon0122, 
putative aldouronate transport system (permease protein); Smon0123, putative aldouronate transport system 
(substrate-binding protein); Smon0124, PL family 12 heparinase II/III family protein (HepC); Smon0125, PL 
family 8 hyaluronate lyase (HysA); Smon0126, sulfatase; Smon0127, GH family 88 unsaturated chondroitin disac-
charide hydrolase (UGL); Smon0128, hypothetical protein.
Some streptococci can assimilate hyaluronan as a sole carbon source25, 26, and PTS encoded in the strepto-
coccal GAG genetic cluster is suitable for import of unsaturated hyaluronan disaccharides containing no sulfate 
groups (Fig. 1, left). On the other hand, unsaturated disaccharides with a sulfate group at the C-6 position gen-
erated from sulfated GAGs, e.g., chondroitin sulfate C, are unsuitable for PTS substrates. The ABC transporter 
possibly enables bacteria to incorporate sulfated disaccharides. Thus, degradation and import systems of GAGs 
were analyzed in S. moniliformis.
S. moniliformis degrades GAGs. To investigate degradation of GAGs by S. moniliformis, a plate method 
for halo detection27 was adopted (Fig. 3). Bacterial cells were grown on nutrient medium plates containing bovine 
serum albumin (BSA) and each of the GAGs, and acetic acid was poured on the plates after colony formation. 
Degradation of GAGs caused clear zones, halos, although GAGs resulted in formation of white precipitates due 
to interaction with BSA in the presence of acetic acid. Hyaluronan, chondroitin sulfate C, and heparin were 
used as substrates. Chondroitin sulfate is classified as chondroitin sulfates A, B, and C based on position of the 
sulfate group28. Chondroitin sulfate C is sulfated at the C-6 position of GalNAc, while chondroitin sulfates A 
and B are sulfated at the C-4 position of GalNAc. The repeating units of chondroitin sulfates A, B, and C are 
GlcUA-GalNAc4S (GalNAc with a sulfate group at C-4 position), IdoUA-GalNAc4S, and GlcUA-GalNAc6S 
(GalNAc with a sulfate group at C-6 position), respectively29. Gram-negative Pedobacter heparinus is known to 
degrade hyaluronan, chondroitin sulfate, and heparin30 and served as a positive control, while Escherichia coli 
served as a negative control.
P. heparinus cells formed halos on each GAG plate after addition of acetic acid (Fig. 3B; plates 1, 2, and 3 on 
the right), while no halo formation was observed on E. coli plates (Fig. 3C; plates 1, 2, and 3 on the right). In the 
case of S. moniliformis, halos were observed on plates containing hyaluronan or chondroitin sulfate C (Fig. 3A; 
plates 1 and 2, right). Surprisingly, the bacterium did not grow in the presence of heparin (Fig. 3A; plate 3, left). 
S. moniliformis in the presence of hyaluronan and chondroitin sulfate C in the nutrient medium grew better than 
when in the absence of GAG (Fig. S1).
Expression of the GAG genetic cluster in S. moniliformis. Because S. moniliformis degrades hyaluro-
nan and chondroitin sulfate C, the expression of the bacterial GAG genetic cluster was examined by immunoblot 
analysis. The molecular masses of Smon0123 and Smon0127 were estimated to be 57 and 46 kDa, respectively, 
although Smon0123 was predicted to contain a signal peptide with a molecular mass of 2 kDa by a LipoP pro-
gram31. As described later, anti-Smon0123 antibodies were prepared using recombinant Smon0123 as anti-
gens. As Smon0127 exhibits a significant sequence identity (48%) with Streptococcus pyogenes UGL (SpyUGL), 
Figure 3. Degradation of GAGs. (A) S. moniliformis. (B) P. heparinus as a positive control. (C) E. coli as a 
negative control. Plates on the left and right represent before and after addition of acetic acid, respectively. Plates 
1, 2, and 3 contained hyaluronan, chondroitin sulfate C, and heparin, respectively.
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anti-SpyUGL antibodies12 were used to detect Smon0127. The purified recombinant Smon0123 and Streptococcus 
agalactiae UGL (SagUGL)32 were subjected to immunoblotting as the positive control (Fig. 4A and B, lane 5). 
Both Smon0123 and Smon0127 were constitutively expressed in bacterial cells grown in the GAG-free medium 
(Fig. 4A and B, lane 1). The intensity of both protein bands increased in the presence of GAG, particularly hyalu-
ronan (Fig. 4A and B, lane 2). These results indicated that the GAG genetic cluster was constitutively expressed in 
S. moniliformis cells and that its expression was enhanced in the presence of GAG.
Enzymatic properties of Smon0127. To investigate the enzymatic properties of Smon0127 expressed 
in bacterial cells, the overexpression system of Smon0127 was constructed in E. coli cells, and recombinant 
Smon0127 was expressed and purified to homogeneity (Fig. 4C). Absorbance at 235 nm derived from the C=C 
double bond in unsaturated hyaluronan disaccharide (ΔHA) decreased by the addition of Smon0127 to the sub-
strate, indicating that Smon0127 functions as UGL. To determine the substrate specificity of Smon0127 UGL, 
various unsaturated GAG disaccharides, such as ΔHA, unsaturated chondroitin disaccharides (CΔ0S, CΔ4S, 
and CΔ6S), and unsaturated heparin disaccharides (HΔ0S and HΔ6S), were used as substrates. The difference in 
each substrate is as follows: CΔ0S, sulfate group-free unsaturated chondroitin disaccharide; CΔ4S, unsaturated 
chondroitin disaccharide with a sulfate group at the C-4 position of GalNAc; CΔ6S, unsaturated chondroitin 
disaccharide with a sulfate group at the C-6 position of GalNAc; HΔ0S, sulfate group-free unsaturated heparin 
disaccharide; and HΔ6S, unsaturated heparin disaccharide with a sulfate group at the C-6 position of GlcNAc.
Smon0127 UGL was the most active on CΔ0S (specific activity, 4.46 units/mg). Specific activities of the 
enzyme toward each substrate were as follows: ΔHA, 2.26 units/mg; CΔ4S, 0.342 units/mg; CΔ6S, 0.272 units/
mg; HΔ0S, 0.0441 units/mg; and HΔ6S 0.0436 units/mg. The kinetic parameters of Smon0127 UGL are shown 
in the Supplementary Information.
Interaction between Smon0123 and unsaturated GAG disaccharides. Recombinant Smon0123, 
the putative solute-binding protein, was expressed in E. coli cells, purified to homogeneity (Fig. 4D), and sub-
jected to differential scanning fluorimetry (DSF)33 to examine the interaction between Smon0123 and unsatu-
rated GAG disaccharides (Fig. 5A). Our previous report evidenced that this method is feasible for analyzing the 
interaction between the solute-binding protein and the substrate34. In DSF, the reaction temperature was escalated 
in the mixture of a protein, ligand, and fluorescent chemical (SYPRO Orange). The relative fluorescent unit (RFU) 
was changed due to the formation of hydrophobic interaction between unfolded protein and SYPRO Orange. The 
inflection point of the increase on the RFU is defined as the melting temperature (Tm)33. As the ligand-bound 
protein is thermally more stable than the ligand-free form due to the conversion of the rigid form, Tm in the pres-
ence of a ligand was higher than that in the absence of a ligand. Generally, the solute-binding protein adopts two 
conformations during substrate binding, substrate-free open form and substrate-bound closed form35, indicating 
that there is a transitional state (substrate-bound open form) in the conformational change. This conformational 
change due to the interaction between the protein and the ligand is represented as two Tm values, Topen and Tclosed, 
corresponding to the substrate-bound open form and substrate-bound closed form, respectively.
Smon0123 in the presence of CΔ0S at 1 mM gave two Tm values (44.4 and 66.0 °C), while Smon0123 in the 
absence of a ligand gave a single Tm value (46.7 °C). Tclosed (66.0 °C) was significantly higher than Tm (46.7 °C) 
(Fig. 5A, middle), suggesting that Smon0123 had a significant affinity with CΔ0S through the conformational 
change. On the other hand, the fluorescence profile of Smon0123 in the presence of the non-GAG disaccharide, 
N,N′-diacetylchitobiose (single Tm, 45.6 °C) at 1 mM was comparable with that in the absence of ligand. Various 
unsaturated GAG disaccharides were used at 50 µM in a similar manner (Fig. 5A, lower). Two Tm values (Topen and 
Tclosed) of Smon0123 in the presence of CΔ0S, CΔ4S, CΔ6S, or ΔHA were detected, while each single Tm value 
of Smon0123 in the presence of HΔ0S, HΔ6S, or HΔNS6S (unsaturated heparin disaccharide with two sulfate 
groups at the N position and C-6 position of GlcNAc) kept low at around 45 °C. These data suggest that Smon0123 
binds to unsaturated GAG disaccharides with the 1,3-glycoside bond (CΔ0S, CΔ4S, CΔ6S, and ΔHA) rather 
than the 1,4 bond (HΔ0S, HΔ6S, and HΔNS6S).
Due to the difficulty in determining the affinity level by DSF, interactions between Smon0123 and unsaturated 
GAG disaccharides were further analyzed by measuring the fluorescence intensity of Smon0123 in the presence 
or absence of ligands (Fig. 5B). The fluorescence intensity derived from tryptophan residues of Smon0123 propor-
tionally decreased to increasing ligand concentrations (Fig. 5B, upper). The ratio of decreasing fluorescence inten-
sity was plotted with respect to ligand concentration, and the dissociation constants were determined from the 
saturation curve (Fig. 5B, middle). Smon0123 showed the highest affinity with CΔ0S (Kd, 0.635 ± 0.122 µM), fol-
lowed by ΔHA, CΔ4S, and CΔ6S (Fig. 5B, lower). The affinity level of Smon0123 with unsaturated heparin disac-
charides was low. Although Kd values for N,N′-diacetylchitobiose (7.50 ± 1.26 µM) or cellobiose (5.41 ± 0.606 µM) 
were also calculated, these were estimated to basal levels in this assay. The binding ability of Smon0123 to GAG 
polysaccharides (hyaluronan, chondroitin sulfate C, and heparin) was also investigated and no specific interac-
tion between Smon0123 and these GAG polysaccharides was observed.
Crystal structure of Smon0123. Because Smon0123 exhibited an affinity with sulfate-free and -bound 
unsaturated chondroitin disaccharides (CΔ0S, CΔ4S, and CΔ6S), the binding mode of Smon0123 to these sub-
strates was analyzed by X-ray crystallography. The detailed results regarding crystallization and structure deter-
mination of Smon0123 are shown in the Supplementary Information.
The overall structure of Smon0123 (N-18/C-5) in complex with CΔ0S is shown in Fig. 6B. Although 
Smon0123 (N-18/C-5) consists of 482 amino acid residues, N-terminal 9 amino acid residues (Met1Lys19–Gly26) 
showed no electron density, possibly due to disorder. Crystal structures of ligand-free Smon0123 (N-28/C-5) 
(Fig. 6A) and ligand (CΔ4S or CΔ6S)-bound Smon0123 (N-18/C-5) were also determined by molecular 
replacement with CΔ0S-bound Smon0123 (N-18/C-5). Smon0123 is composed of two major domains (N- and 
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Figure 4. Expression and characterization of binding protein-dependent ABC transporter. SDS-PAGE followed 
by immunoblotting using anti-Smon0123 antibodies (A) and anti-SpyUGL antibodies (B). S. moniliformis 
cells grown in liquid nutrient medium (100 μl) in the presence or absence of GAG (hyaluronan or chondroitin 
sulfate (C) were collected at OD600 = 0.37 by centrifugation. The cells were lysed with SDS, and the resultant cell 
lysates were subjected to immunoblotting for detection of Smon0123 (solute-binding protein) and Smon0127 
(UGL) encoded in the GAG genetic cluster. Lane M, protein standards with molecular masses of 120, 100, 80, 
60, 50, 40, 30, and 20 kDa used for immunoblotting; lane 1, S. moniliformis cells in the absence of GAG; lane 2, 
S. moniliformis cells in the presence of hyaluronan; lane 3, S. moniliformis cells in the presence of chondroitin 
sulfate C; lane 4, E. coli cells in the absence of GAG; lane 5, positive control [purified Smon0123 (A) and 
SagUGL (B)]. (C) and (D) SDS-PAGE followed by staining with Coomassie Brilliant Blue (CBB). Lane M, 
protein standards with molecular masses of 250, 150, 100, 75, 50, 37, 25, and 20 kDa for CBB staining; lane 1, 
purified Smon0127 (C) and Smon0123 (D). (E) Elution profile of Smon0121-Smon0122(10xHis)/Smon0120-
Smon0120 via gel filtration chromatography. Left and right-sided peaks show an aggregate and a tetramer, 
respectively. Volumes required for elution of the standard ferritin (440 kDa) and aldolase (158 kDa) are 
indicated by black arrows. (F) SDS-PAGE followed by CBB staining. Lane M, protein standards with molecular 
masses of 250, 150, 100, 75, 50, 37, 25, and 20 kDa; lane 1, purified Smon0121-Smon0122(10xHis)/Smon0120-
Smon0120. (G) Immunoblotting using anti-histidine tag antibodies. Lane M, protein standards with molecular 
masses of 120, 100, 80, 60, 50, 40, 30, and 20 kDa; lane 1, purified Smon0121-Smon0122(10xHis)/Smon0120-
Smon0120. (H) ATPase activity of the Smon0121-Smon0122(10xHis)/Smon0120-Smon0120 in liposomes in 
the presence or absence of various disaccharides. PLS, proteoliposome without disaccharides; chitobiose, N,N′-
diacetylchitobiose; d2M, unsaturated alginate disaccharide. The ATPase activity in PLS was considered 100%. 
Each data represents the average of triplicate individual experiments (means ± standard errors of the means).
www.nature.com/scientificreports/
7Scientific RepoRts | 7: 1069  | DOI:10.1038/s41598-017-00917-y
C-domains), and each domain has two small subdomains. N-domain is constituted by residues Pro27–Ile151 (N1 
subdomain) and residues Gly328–Ala418 (N2 subdomain), and C-domain contains residues Lys152–Gly327 (C1 
subdomain) and Lys419–Phe500 (C2 subdomain). Each domain included a parallel and an antiparallel β-sheet 
surrounded by many α-helices and formed the α/β sandwich structure. Both N- and C-domains were connected 
through three loops: residues Tyr146–Ser154 (N1-C1), residues Arg319–Thr324 (C1-N2), and residues Ala414–
Ser415 (N2-C2). The ligand CΔ0S was bound to a cleft formed between the two N- and C-domains (Fig. 6B). A 
metal ion, possibly, a calcium ion based on its coordination, was located in the C-domain, far from the cleft. All 
the crystal structures of Smon0123 so far determined include metal ion in its molecule, suggesting that the metal 
ion contributes to protein folding. Because the metal ion is situated far from the substrate-biding site, the metal 
ion probably has no influence on the substrate-binding ability. Compared with the structure of CΔ0S-bound 
Smon0123 and that of ligand-free Smon0123, the N- and C-domains of ligand-bound Smon0123 were 47° more 
closed than those of ligand-free Smon0123 (Fig. 6C). There was no significant difference in the overall structure 
among Smon0123 proteins in complex with CΔ0S, CΔ4S, and CΔ6S.
Binding mode of Smon0123 to unsaturated GAG disaccharides. Interactions between Smon0123 
and each unsaturated chondroitin disaccharide (CΔ0S, CΔ4S, or CΔ6S) are shown in Table 1 and Fig. 7. 
Unsaturated GAG disaccharides were bound to the cleft of Smon0123 by hydrogen bonds and van der Waals 
(C-C) contacts. The numbers of hydrogen bonds between Smon0123 and unsaturated chondroitin disaccharides 
Figure 5. Affinity of Smon0123 with unsaturated GAG disaccharides. (A) DSF analysis. Upper, fluorescence 
profile of Smon0123 with C∆0S (green: 0 mM and cyan: 1 mM) or 1 mM N,N′-diacetylchitobiose (red). Middle, 
negative derivative curve plot derived from the fluorescence profile. Lower, the values of Topen and Tclosed in the 
presence or absence of various unsaturated GAG disaccharides. (B) Fluorescence spectrum analysis. Upper, 
wavelength-scanned fluorescence intensity of Smon0123 with C∆0S (blue: 0 μM; red: 0.25 μM; green: 0.50 μM; 
purple: 0.75 μM; cyan: 1.0 μM; orange: 2.0 μM; lilac: 5.0 μM; pink: 10 μM; and olive: 20 μM). Middle, the relative 
fluorescence intensity by addition of increasing ligand concentrations was plotted after modification based on 
volume change in the cuvette. Kd was determined using the least-squares method. Lower, dissociation constants 
of Smon0123 with various unsaturated GAG disaccharides. Chitobiose, N,N′-diacetylchitobiose.
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are 9 for CΔ0S (ΔGlcUA, 4; GalNAc, 5), 14 for CΔ4S (ΔGlcUA, 4; GalNAc4S, 10), and 8 for CΔ6S (ΔGlcUA, 4; 
GalNAc6S, 4). The numbers of C-C contacts between Smon0123 and unsaturated chondroitin disaccharides are 
50 for CΔ0S (ΔGlcUA, 27; GalNAc, 23), 48 for CΔ4S (ΔGlcUA, 26; GalNAc4S, 22), and 53 for CΔ6S (ΔGlcUA, 
28; GalNAc6S, 25). Smon0123 strictly recognized both residues of unsaturated uronate (ΔGlcUA) and amino 
sugar (GalNAc/GalNAc4S/GalNAc6S). An aromatic residue, Trp284, showed stacking interactions with both 
ΔGlcUA and GalNAc/GalNAc4S/GalNAc6S. Numerous water molecules mediated indirect interactions between 
Smon0123 and unsaturated chondroitin disaccharides by the formation of hydrogen bonds. Basic residues 
directly or indirectly binding to the sulfate group of CΔ4S (Arg204 and Arg393) and CΔ6S (Arg204 and Lys210) 
formed a positively charged space for accommodating the sulfate group.
Expression and purification of membrane-bound ABC transporter. Because Smon0123 was identified as 
an unsaturated GAG disaccharide-binding protein, the cooperative function of Smon0123 and ABC transporter, inter-
acting with each other at the ratio of one to one, should be focused. However, it is difficult to analyze a membrane-bound 
protein with hetero-subunits. The S. moniliformis ABC transporter is considered to consist of tetramer subunits of two 
membrane-spanning subunits (Smon0121-Smon0122) and ATP-binding subunits (Smon0120-Smon0120) by pri-
mary structure-based (homology and topology) analysis. The recombinant ABC transporter (Smon0121-Smon0122/
Smon0120-Smon0120) was successfully expressed in E. coli cells and purified from the cell membrane to homogeneity 
by the suitable construction of the expression system of protein subunits and their solubilization with detergents.
Three genes (smon0120, smon0121, and smon0122) coding for Smon0120, Smon0121, and Smon0122, respec-
tively, locate sequentially in that order in the S. moniliformis genome and form the operon structure (Fig. 2B). Thus, 
Figure 6. Overall structures of Smon0123. Structures (stereo-diagram with wall-eyed viewing) of ligand-free 
Smon0123 (N-28/C-5) (A) and CΔ0S-bound Smon0123 (N-18/C-5) (B). Cyan, α-helices; purple, β-strands; 
pink, loops and coils. CΔ0S bound to Smon0123 is shown in ball model (green, carbon atom; red, oxygen atom; 
and blue, nitrogen atom). Orange ball shows the metal ion. Structural comparison with ligand-free Smon0123 
(N-28/C-5) (olive) and CΔ0S-bound Smon0123 (N-18/C-5) (blue) (C). Both N-domains of ligand-free and 
-bound Smon0123 proteins were superimposed. There is a structural difference (47° in angle) in the N- and 
C-domains between C∆0S-free and -bound Smon0123.
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van der Waals (C-C distance <4.5 Å)
Smon0123 (N-18/C-5)/C∆0S Smon0123 (N-18/C-5)/C∆4S Smon0123 (N-18/C-5)/C∆6S
Sugar Atom Protein/Water Atom Distance Sugar Atom Protein/Water Atom Distance Sugar Atom Protein/Water Atom Distance
ΔGlcUA C1 Trp284 CE2 4.31 ΔGlcUA C1 Trp284 CD2 4.22 ΔGlcUA C1 Trp284 CD2 4.06
C1 Trp284 CE3 3.93 C1 Trp284 CE3 4.00 C1 Trp284 CE3 3.91
C1 Trp284 CZ2 4.31 C1 Trp284 CE2 4.39 C1 Trp284 CE2 4.29
C1 Trp284 CZ3 3.89 C1 Trp284 CZ3 3.94 C1 Trp284 CZ3 3.90
C1 Trp284 CH2 4.10 C1 Trp284 CH2 4.12 C1 Trp284 CH2 4.13
C1 Trp284 CD2 4.13 C1 Trp284 CZ2 4.36 C1 Trp284 CZ2 4.33
C3 Trp284 CE3 4.27 C3 Trp284 CE3 4.20 C1 Leu389 CD2 4.21
C3 Trp284 CZ3 4.14 C3 Trp284 CZ3 4.05 C2 Leu389 CD2 4.09
C3 Arg322 CZ 4.37 C3 Arg322 CZ 4.38 C3 Trp284 CZ3 4.14
C3 Glu410 CD2 4.05 C3 Glu410 CD 4.09 C3 Trp284 CE3 4.30
C4 Trp284 CE3 3.81 C4 Trp284 CE3 3.86 C3 Glu410 CD 4.05
C4 Trp284 CZ3 4.17 C4 Trp284 CZ3 4.18 C4 Trp284 CE3 3.78
C4 Leu389 CD2 4.34 C4 Leu389 CD2 4.28 C4 Trp284 CZ3 4.14
C4 Glu410 CD 3.91 C4 Glu410 CD 3.88 C4 Leu389 CD2 4.13
C5 Trp284 CE3 3.58 C5 Trp284 CB 4.24 C4 Glu410 CD 3.90
C5 Trp284 CZ3 4.22 C5 Trp284 CG 4.25 C5 Trp284 CB 4.09
C5 Trp284 CB 4.14 C5 Trp284 CD2 3.93 C5 Trp284 CG 4.16
C5 Trp284 CG 4.19 C5 Trp284 CE3 3.58 C5 Trp284 CD2 3.91
C5 Trp284 CD2 3.91 C5 Trp284 CZ3 4.19 C5 Trp284 CE3 3.60
C5 Leu389 CD2 3.70 C5 Leu389 CD2 3.71 C5 Trp284 CZ3 4.25
C6 Trp284 CE3 4.00 C6 Trp284 CB 3.43 C5 Leu389 CD2 3.50
C6 Trp284 CB 3.36 C6 Trp284 CG 3.87 C6 Trp284 CG 3.88
C6 Trp284 CG 3.87 C6 Trp284 CD2 4.01 C6 Trp284 CD2 4.10
C6 Trp284 CD2 4.07 C6 Trp284 CE3 3.91 C6 Trp284 CE3 4.04
C6 Ser287 CB 3.70 C6 Ser287 CB 3.66 C6 Trp284 CB 3.32
C6 Leu389 CD2 3.79 C6 Leu389 CD2 3.70 C6 Ser287 CA 4.38
C6 Trp413 CH2 4.38 GalNAc4S C1 Leu326 CD2 4.18 C6 Ser287 CB 3.62
GalNAc C1 His36 CE1 4.29 C2 His36 CE1 4.38 C6 Leu389 CD2 3.69
C1 Leu326 CD2 4.20 C3 Trp284 CE2 4.10 GalNAc6S C1 His36 CE1 4.34
C2 His36 CE1 3.95 C3 Trp284 CH2 4.36 C1 Leu37 CD2 4.39
C3 Trp284 CE2 4.02 C3 Trp284 CZ2 3.97 C1 Leu326 CD2 4.06
C3 Trp284 CZ2 3.90 C4 Trp284 CD1 4.39 C2 His36 CE1 4.35
C3 Trp284 CH2 4.31 C4 Trp284 CE2 4.08 C3 Trp284 CE2 3.97
C4 Trp284 CE2 3.96 C4 Trp284 CZ2 4.40 C3 Trp284 CZ2 3.89
C4 Trp284 CZ2 4.31 C5 Trp284 CD1 4.22 C3 Trp284 CH2 4.31
C4 Trp284 CD1 4.25 C5 Trp284 CE2 3.99 C4 Trp284 CD1 4.06
C5 Trp284 CE2 4.06 C5 Trp284 CZ2 4.28 C4 Trp284 CD2 4.26
C5 Trp284 CZ2 4.35 C6 Leu37 CD2 4.22 C4 Trp284 CE2 3.80
C5 Trp284 CD1 4.25 C6 Arg204 CZ 4.30 C4 Trp284 CZ2 4.20
C6 Leu37 CD2 4.23 C6 Trp284 CD1 4.24 C5 Trp284 CD1 4.08
C6 Arg204 CZ 4.24 C7 His36 CE1 4.02 C5 Trp284 CE2 3.92
C6 Trp284 CD1 4.21 C7 Tyr146 CE1 4.28 C5 Trp284 CZ2 4.25
C7 His36 CE1 3.95 C7 Tyr146 CZ 4.29 C6 Arg204 CZ 4.34
C7 Tyr146 CZ 4.35 C7 Leu326 CD2 4.31 C6 Trp284 CD1 3.96
C7 Tyr146 CE1 4.31 C8 Tyr146 CE1 3.57 C7 His36 CE1 3.88
C7 Leu326 CD2 4.21 C8 Tyr146 CZ 3.62 C7 Tyr146 CE1 4.32
C8 Tyr146 CZ 3.76 C8 Leu326 CD2 4.17 C7 Tyr146 CZ 4.33
C8 Tyr146 CE1 3.70 C8 Arg400 CG 4.20 C7 Leu326 CD2 4.22
C8 Leu326 CD2 4.00 C8 Tyr146 CE1 3.73
C8 Arg400 CG 4.05 C8 Tyr146 CZ 3.76
Continued
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van der Waals (C-C distance <4.5 Å)
Smon0123 (N-18/C-5)/C∆0S Smon0123 (N-18/C-5)/C∆4S Smon0123 (N-18/C-5)/C∆6S
Sugar Atom Protein/Water Atom Distance Sugar Atom Protein/Water Atom Distance Sugar Atom Protein/Water Atom Distance
C8 Leu326 CD2 4.00
C8 Arg400 CB 4.30
C8 Arg400 CG 3.93
Hydrogen bonds (<3.3 Å)
Smon0123 (N-18/C-5)/C∆0S Smon0123 (N-18/C-5)/C∆4S Smon0123 (N-18/C-5)/C∆6S
Sugar Atom Protein/Water Atom Distance Sugar Atom Protein/Water Atom Distance Sugar Atom Protein/Water Atom Distance
ΔGlcA O2 Gln405 NE2 2.86 ΔGlcA O2 Gln405 NE2 2.85 ΔGlcA O2 Gln405 NE2 2.99
O3 Tyr409 OH 2.73 O3 Tyr409 OH 2.87 O3 Glu410 OE2 2.68
O3 Glu410 OE2 2.68 O3 Glu410 OE2 2.69 O3 Tyr409 OH 2.68
O6A Ser287 N 2.97 O6A Ser287 N 2.99 O6A Ser287 N 2.87
O2 water80 2.74 O2 water4 2.73 O2 water770 2.74
O6A water52 2.74 O6A water6 2.81 O6A water757 2.78
O6B water143 2.69 GalNAc4S O1S Arg393 NE 2.72 O6B water767 2.55
GalNAc O3 Arg393 NH2 2.91 O1S Arg393 NH2 3.00 GalNAc6S O3 Arg393 NH2 2.96
O6 Lys210 NZ 2.85 O2S Arg204 NH1 3.10 O3S Arg204 O 3.2
O7 His36 NE2 2.83 O2S Arg204 NH2 2.83 O7 His36 NE2 2.81
O7 Arg393 NH2 3.10 O3S Arg204 NH1 3.17 N Tyr146 OH 2.86
N2 Tyr146 OH 2.92 O3 Arg393 NH2 2.91 O1S water766 3.17
O1 water72 2.58 O6 Lys210 NZ 2.8 O2S water795 2.49
O4 water143 2.69 O7 His36 NE2 2.88 O4 water767 2.67
O6 water55 2.69 O7 Arg393 NH2 3.08 O7 water770 2.95
O6 water621 2.57 N Tyr146 OH 2.88
O7 water80 2.94 O1S water56 2.8




Table 1. Interactions between Smon0123 and unsaturated GAG disaccharides
this operon (smon0120-0121-0122) was inserted into an E. coli expression vector with a slight modification of 10 
histidine residues added at the C-terminus of Smon0122. E. coli cell membranes expressing the ABC transporter 
were obtained from the cell extract by ultracentrifugation and were solubilized with n-dodecyl-β-d-maltoside 
(DDM). The transporter was purified by a metal affinity chromatography (Ni-NTA) and gel filtration chromatog-
raphy (HiLoad 16/60 Superdex 200 pg). The sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis 
(PAGE) profile indicated that the purified sample contained three protein bands corresponding to the transmem-
brane domain (Smon0121-Smon0122) and ATPase domain (Smon0120) (Fig. 4F). Furthermore, the protein band 
corresponding to Smon0122 was detected by immunoblotting using anti-histidine tag antibodies (Fig. 4G). The 
ABC transporter seemed to have been eluted as a tetramer (theoretical molecular mass of approximately 150 kDa) 
in size on gel filtration (Fig. 4E, red arrow), although the eluted protein was thought to have molecular mass of 
slightly over 158 kDa based on the elution volume. This difference in molecular mass was possibly due to the pres-
ence of a detergent in the eluted buffer. These results clearly demonstrate the tetramer formation of the purified 
ABC transporter [Smon0121-Smon0122(10xHis)/Smon0120-Smon0120].
Enhancement of ATPase activity of the ABC transporter by Smon0123 and unsaturated 
GAG disaccharides. Because ABC transporters generate the energy of ATP hydrolysis to transport sub-
strates36, the ATPase activity of the purified Smon0121-Smon0122(10xHis)/Smon0120-Smon0120 was meas-
ured to investigate the import of unsaturated GAG disaccharides by the ABC transporter. Although purified 
Smon0121-Smon0122(10xHis)/Smon0120-Smon0120 in the soluble form with detergents exhibited ATPase 
activity, there was no significant difference in the activity between the presence and absence of Smon0123 and/or 
unsaturated GAG disaccharides. Thus, the assay was performed using a proteoliposome37.
The purified Smon0121-Smon0122(10xHis)/Smon0120-Smon0120 was reconstructed in liposomes consti-
tuted by phospholipids. Various disaccharides were added to the proteoliposome in the presence of Smon0123, 
and the phosphate ion liberated through ATP hydrolysis was measured by the molybdenum blue method38 
(Fig. 4H). The ATPase activity in the presence of non-GAG disaccharides as the negative control such as 
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Figure 7. Binding mode of Smon0123 to unsaturated GAG disaccharides. Interactions between Smon0123 
and CΔ0S (A), CΔ4S (B), or CΔ6S (C). CΔ0S, CΔ4S, and CΔ6S are shown in sticks (green, carbon atom; red, 
oxygen atom; blue, nitrogen atom; and yellow, sulfur atom) (stereo-diagram with wall-eyed viewing). Carbon 
atoms of Smon0123 residues interacting with the substrates are shown in gray lines. Direct and water-mediated 
hydrogen bonds between Smon0123 and substrates are shown in dashed lines colored with magenta and cyan, 
respectively. Water molecules (oxygen atoms) are shown as cyan balls. (D) Large space for sulfate groups of 
substrates. In the interaction between Smon0123 and CΔ0S (left), a number of water molecules are located in 
the space where a sulfate group of CΔ6S is accommodated (right).
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cellobiose and unsaturated alginate disaccharide (d2M) except for N,N′-diacetylchitobiose was compara-
ble with that in the absence of disaccharides (PLS). The enhancement of the ATPase activity in the presence 
of N,N′-diacetylchitobiose was probably due to the similarity in component between GAG disaccharides and 
N,N′-diacetylchitobiose. Unsaturated hyaluronan and chondroitin disaccharides (ΔHA, CΔ0S, CΔ4S, and 
CΔ6S) significantly enhanced the ATPase activity of the proteoliposome, while the enzyme activity in the pres-
ence of unsaturated heparin disaccharides (HΔ0S and HΔ6S) was comparable with that in PLS.
Discussion
In the present study, we found and characterized the bacterial solute-binding protein-dependent ABC trans-
porter for the import system of GAGs for the first time, although a few ABC exporters for GAGs have already 
been identified in bacteria39, 40 and humans41. While PTS phosphorylates substrates at the C-6 position during 
transport, the ABC transporter imports substrates without any substrate modification. The S. moniliformis ABC 
transporter was demonstrated to be active on various unsaturated GAG disaccharides, particularly unsaturated 
sulfate group-free chondroitin and hyaluronan disaccharides and uniquely (relative to PTS GAG disaccharide 
import) unsaturated chondroitin disaccharide with a sulfate group at the C-6 position of GalNAc (C∆6S), which 
is an unsuitable substrate for PTS.
Based on the above-mentioned results and streptococcal GAG assimilation system12 (Fig. 1, left), the corre-
sponding Streptobacillus model for the degradation and import of GAG was postulated in Fig. 1, right. Because PL 
family 8 hyaluronate lyase is active on hyaluronan and chondroitin sulfate42, extracellular GAGs such as hyaluro-
nan and chondroitin sulfate are depolymerized to unsaturated disaccharides by hyaluronate lyase(s) (Smon0117 
and/or Smon0125). Similarly, heparinase (Smon0124) probably acts on extracellular heparin and heparan sul-
fate. The resultant unsaturated disaccharides are imported to the periplasm through the outer membrane by 
an unknown channel/transporter. A periplasmic solute-binding protein (Smon0123) captures unsaturated GAG 
disaccharides with the 1,3-glycoside bond and delivers substrates to an ABC transporter localized in the cytoplas-
mic membrane. The ABC transporter consists of four subunits (Smon0121-Smon0122/Smon0120-Smon0120) 
and incorporates unsaturated disaccharides into the cytoplasm with an energy derived through ATP hydrolysis. 
Because the localization prediction tool PSORT-B43 suggests that sulfatase (Smon0126) and UGL (Smon0127) 
are localized in the cytoplasm, unsaturated disaccharides are degraded to constituent monosaccharides in the 
cytoplasm by GH 88 hydrolase UGL (Smon0127) before and/or after desulfation by sulfatase (Smon0126). In 
fact, Smon0127 UGL was found to be expressed in the bacterial cells. No sulfatase activity toward C∆4S was 
detected in the extracellular fraction (Supplementary Information). The Smon0127 UGL showed a preference for 
non-sulfated GAG disaccharides, although sulfated GAG disaccharides were also degraded by the enzyme. The 
substrate specificity of Smon0127 UGL suggests that the sulfatase reaction probably occurs before degradation to 
constituent monosaccharides by UGL.
Smon0123 was demonstrated to bind to unsaturated hyaluronan and chondroitin disaccharides by DSF 
and fluorescent spectrum analysis (Fig. 5). The substrate specificity of Smon0123 coincided with that of 
Smon0121-Smon0122(10xHis)/Smon0120-Smon0120 for ATPase activity (Fig. 4H), indicating that the ABC 
transporter interacts with substrate-bound Smon0123 (closed form), but not the substrate-free form, and triggers 
ATP hydrolysis. Distinct from substrate-free Smon0123 in the open conformation, the binding protein in com-
plex with the substrate adopts the closed conformation by accommodating the substrate at the cleft between the 
N- and C-domains (Fig. 6B). Therefore, the closed conformation of substrate-bound Smon0123 is considered to 
be important for association with the ABC transporter.
Structure determination of Smon0123 with CΔ6S is particularly important because this result directly demon-
strates that CΔ6S, unsuitable for PTS, becomes a substrate for the S. moniliformis ABC transporter. The bind-
ing mode of Smon0123 to unsaturated chondroitin disaccharides is discussed as follows. The cleft of Smon0123 
seems to have spatial allowance. In the interaction between Smon0123 and CΔ0S, numerous water molecules are 
located in the space where a sulfate group of CΔ4S or CΔ6S is accommodated (Fig. 7D). The sulfate group of 
each substrate is situated close to the binding site of Smon0123 and directly forms hydrogen bonds with several 
residues of Smon0123. The C-C contacts of Smon0123 with C∆6S also increase compared with those with CΔ0S. 
In addition, the pyranose ring of amino sugar in unsaturated GAG disaccharide with 1,4-glycoside bond would 
be in reverse to that in unsaturated chondroitin disaccharide, suggesting that the low affinity of Smon0123 with 
unsaturated GAG disaccharides with 1,4-glycoside bond is due to this structural difference in arrangement of the 
pyranose ring.
Judging from the substrate specificity of Smon0123 (binding protein) and Smon0127 (UGL), the degradation 
of hyaluronan and chondroitin sulfate by S. moniliformis is reasonable (Fig. 3A, 1 and 2, right). Heparin is lethal 
for this bacterium (Fig. 3A, 3, left), although putative heparinase (Smon0124) is encoded in the GAG genetic 
cluster (Fig. 2). There is a possibility that heparin oligosaccharide produced from heparin by putative heparinase 
inhibits bacterial growth. This result suggests that heparin is extremely scarce at the colonization site of S. monil-
iformis, contributing to the compositional analysis of GAGs in extracellular matrices of animal cells. There is a 
possibility that heparin is rich in the oral cavity in humans but scarce in rodents. Heparin is expected to become 
a potential anti-Streptobacillus agent.
S. moniliformis is normally indigenous to rodent oral cavity and belongs to a phylum of fusobacteria. 
Fusobacteria such as Fusobacterium and Leptotrichia usually inhabit the oral cavity and gastrointestinal tract of 
animals including humans44. Non-sulfated hyaluronan as well as sulfated GAGs such as chondroitin sulfate are 
abundant in animal oral cavities45. GAGs provide structures of tissues with a strong network due to the high water 
absorption. Gingiva in the oral mucosa is known to contain particularly rich sulfated GAGs due to the high pres-
sure of mastication46. Besides, dermatan sulfate and chondroitin sulfate are rich in connective tissues of the oral 
mucosa and connective tissue papilla of the anterior and posterior palate in rodents45. Therefore, the degradation 
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and import systems of sulfated GAGs in S. moniliformis are feasible for its colonization in rodent oral cavities, 
abundant in sulfated GAGs.
Homologous genes with S. moniliformis ABC transporter genes are found in the genome of some fusobacte-
ria. Fusobacterium mortiferum (NCBI BioProject ID, 32421) and Leptotrichia goodfellowii (NCBI BioProject ID, 
43669) form the GAG genetic cluster including ABC transporter genes in bacterial genomes, indicating that the 
GAG import system is common to these fusobacteria. Some fusobacteria are pathogenic and cause infection in 
some organs and tissues such as the lung, head neck, cranium, and meninx47. This fusobacterial system for the 
degradation and import of GAG may be involved in colonization and/or infection to host cells, and inhibitors for 
the bacterial system are expected to develop novel therapy agents.
In conclusion, for the first time, the bacterial import system of sulfated and non-sulfated GAGs was identified 
as the solute-binding protein-dependent ABC transporter and clarified to be functionally expressed in pathogenic 
S. moniliformis through molecular and structural biology.
Materials and Methods
Materials. Unsaturated chondroitin disaccharides (CΔ0S, CΔ4S, and CΔ6S) were purchased from Seikagaku 
Biobusiness. Unsaturated hyaluronan disaccharide (ΔHA) and unsaturated heparin disaccharides (HΔ6S 
and HΔNS6S) were purchased from Sigma-Aldrich. A sulfate group-free HΔ0S (heparin disaccharide IV-A) 
was purchased from Dextra. SYPRO Orange (Invitrogen), DDM (Nacalai tesque), and n-octyl-β-d-glucoside 
(n-OG) (Dojindo) were commercially available. Oligonucleotides were synthesized by Hokkaido System Science. 
Restriction endonucleases and DNA-modifying enzymes were purchased from Toyobo. All other analytical grade 
chemicals used in this study were commercially available.
Microorganisms, construction of the overexpression system, and protein purifica-
tion. Streptobacillus moniliformis DSM 12112 and its genome were purchased from Deutsche Sammlung von 
Mikroorganismen und Zellkulturen. Its complete genome sequence is available in GenBank under accession 
number, CP001779. This bacterium was statically cultured at 37 °C under 5% CO2 in 0.8% nutrient broth (0.3% 
beef extract and 0.5% peptone) (Difco) containing 20% horse serum (Thermo Fisher Scientific) for 24–48 h. To 
investigate expression of Smon0127 and Smon0123, S. moniliformis cells were cultured in nutrient broth and 
horse serum in the presence or absence of 0.2% GAG [hyaluronic acid (Fluka), chondroitin sulfate C sodium salt 
(Wako), or heparin sodium salt (Nacalai tesque)] dialyzed against pure water. Detailed experimental procedures 
for construction of the overexpression system of S. moniliformis proteins and protein purification are presented 
in Supplementary Information.
Plate method for detection of GAG degradation. Rapid plate method27 was adopted to investigate the 
GAG-degrading ability of S. moniliformis. The bacterial cells were cultured in plates containing 1% BSA (Wako), 
1% agar, 0.2% dialyzed GAG (hyaluronan, chondroitin sulfate C, or heparin), 0.8% nutrient broth, and 20% horse 
serum. After addition of 2 M acetic acid (1 ml) to the cultured plates, the remaining GAG was reacted with BSA 
as white precipitates and clear zones appeared as a halo in GAG-degraded regions.
Immunoblotting. Antibodies to the purified Smon0123(N-18/C-0) were raised in a rabbit and the serum 
was used as polyclonal antibodies against Smon0123. To investigate expression of Smon0123 in S. moniliformis, 
the bacterial cells grown in the presence or absence of GAG were subjected to SDS-PAGE followed by immu-
noblotting using anti-Smon0123 antibodies. Anti-IgG conjugated with horseradish peroxidase (HRP) (GE 
Healthcare) and Immobilon Western Chemiluminescent HRP substrate (Millipore) were used to detect the target 
protein. Anti-SpyUGL antibodies12 were used as a primary antibody for detection of Smon0127. Furthermore, the 
purified Smon0121-Smon0122(10xHis)/Smon0120-Smon0120 was subjected to SDS-PAGE followed by immu-
noblotting using anti-histidine tag antibodies (GE Healthcare).
Enzyme assay. The Smon0127 UGL was assayed by monitoring the decrease of absorbance at 235 nm 
derived from the C=C double bond in unsaturated GAG disaccharides. The assay was conducted at 30 °C in reac-
tion mixture of 20 mM Tris-HCl (pH 7.5), 0.2 mM substrate, and the enzyme. Unsaturated GAG disaccharides, 
ΔHA, CΔ0S, CΔ4S, CΔ6S, HΔ0S, and HΔ6S, were used as substrates. One unit of the enzyme activity was 
defined as the amount of enzyme required to degrade 1 µmol of substrate per minute as described previously12, 48. 
The enzyme was also assayed using various concentrations (0 to 1 mM) of CΔ0S, and kinetic parameters (Km and 
kcat) were determined according the Michaelis-Menten equation (Synergy Software).
DSF. Interactions between Smon0123 and unsaturated GAG disaccharides were investigated by DSF using the 
MyiQ2 real-time PCR instrument (Bio-Rad). The reaction mixture contained 0 and 1 mM each of disaccharides 
(CΔ0S and N,N′-diacetylchitobiose), 50 mM Tris-HCl (pH 7.5), 0.1% SYPRO Orange, and 8.58 µM Smon0123. 
The temperature was increased from 25 to 95 °C by 0.5 °C per cycle (141 cycles). The RFU values derived from 
SYPRO Orange hydrophobically bound to unfolded proteins were measured during the heating. The inflection 
point of the increase in the RFU was determined as melting temperature (Tm). Various disaccharides such as 
CΔ0S, CΔ4S, CΔ6S, ΔHA, HΔ0S, HΔ6S, and HΔNS6S were used at 50 µM as a ligand.
Fluorescence spectrum analysis. The fluorescence intensity of Smon0123 with escalated concentra-
tion of ligands was measured by spectrofluorometer [FP-6500 (JASCO)]. Parameters under reaction conditions 
were determined as follows: excitation band width, 1 nm; emission band width, 10 nm; response, 2 s; sensitiv-
ity, high; excitation wavelength, 280 nm, start to end emission wavelength, 300 to 500 nm; data pitch, 1 nm; 
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and scan speed, 100 nm/min. The reaction mixture contained 0.1 µM Smon0123, 50 mM Tris-HCl (pH 7.5), 
and 0 to 20 µM ligands. Various disaccharides such as CΔ0S, CΔ4S, CΔ6S, ΔHA, HΔ0S, HΔ6S, HΔNS6S, 
N,N′-diacetylchitobiose, and cellobiose were used as a ligand. The interaction between Smon0123 and GAG pol-
ysaccharides such as hyaluronan, chondroitin sulfate C, and heparin was also investigated using BSA as a nega-
tive control. The ratio of decreasing fluorescence intensity by addition of increasing ligands in comparison with 
the intensity in the absence of ligands was plotted and the dissociation constant (Kd) was determined using the 
least-squares method49.
X-ray crystallography. To determine the three-dimensional structure of Smon0123, the purified protein 
was crystallized by sitting drop vapor diffusion. The 1 µl of Smon0123 mutants were mixed with equal volume 
of the reservoir solution for crystallization and a crystal formed at 20 °C for 2 weeks. In the case of ligand-free 
Smon0123 (N-28/C-5), 21.2 mg/ml Smon0123 (N-28/C-5) was crystallized in the drop consisting of 0.2 M potas-
sium sodium tartrate tetrahydrate, 0.1 M tri-sodium citrate dehydrate (pH 5.6), and 2 M ammonium sulfate. The 
12.5 mg/ml Smon0123 (N-18/C-5) was crystallized in the drop containing 1 mM C∆0S, 0.2 M ammonium chlo-
ride, 0.1 M MES (pH 6.0), and 20% (w/v) polyethylene glycol (PEG) 6000 for the complex Smon0123 (N-18/C-5)/
C∆0S; 1 mM C∆4S, 0.2 M ammonium chloride, 0.1 M HEPES (pH 7.0), and 20% (w/v) PEG 6000 for the complex 
Smon0123 (N-18/C-5)/C∆4S; and 1 mM C∆6S, 0.2 M potassium thiocyanate, and 20% (w/v) PEG 3350 for the 
complex Smon0123 (N-18/C-5)/C∆6S. Each single crystal was picked up by a nylon loop, soaked in mother 
liquor containing 20% ethylene glycol as a cryoprotectant, and frozen in a cold nitrogen gas stream on the beam-
line BL-38B1 of SPring-8 (Harima, Japan). X-ray diffraction images were collected with a MAR225HE detector 
(Rayonix) with synchrotron radiation at wavelength 1.00 Å. The data were indexed, integrated, and scaled using 
the HKL-2000 program50. The structure was determined through molecular replacement method with the Molrep 
program51 in the CCP4 program package. Structure refinement was conducted using the phenix refine program 
in the PHENIX program package52. After each refinement cycle, the model was adjusted manually with the win-
Coot program53. Rwork/Rfree values of Smon0123 (N-18/C-5)/C∆0S, Smon0123 (N-18/C-5)/C∆4S, Smon0123 
(N-18/C-5)/C∆6S, and Smon0123 (N-28/C-5) are 17.4/20.5, 19.3/21.8, 19.7/24.8, and 20.7/23.6, respectively. 
The torsion angles of some residues were outlier in the Ramachandran plot analysis due to those distorted β-turn 
structures and ambiguous electron density. Figures of protein structures were prepared using PyMOL54.
Preparation of proteoliposomes. A soybean l-α-phosphatidylcholine type IV-S (Sigma) was dissolved at 
50 mg/ml in 1.5 ml chloroform. Chloroform was removed by rotary evaporation (N-1000-WD, Eyela), and resid-
ual solvent was removed under vacuum for 3 h. The resultant dried lipid films were suspended in 20 mM Tris-HCl 
(pH 8.0) containing 1 mM dithiothreitol (DTT). After sonication 3 to 5 times by probe-type sonicator (Sonics & 
Materials) on ice, the suspension was frozen in liquid nitrogen and thawed at 37 °C. After 3 repeats of freezing and 
thawing, this liposome solution was stored at −80 °C. The liposome was thawed at 37 °C and extruded 17 times 
through a 100 nm polycarbonate membrane by a Mini-Extruder (Avanti Polar Lipids). The 20% n-OG (3.5 µl) 
was added to the filtered liposome (45 µl) and the mixture was kept at room temperature for 5 min. The 4 mg/
ml purified Smon0121-Smon0122(10xHis)/Smon0120-Smon0120 was added to the mixture and kept at room 
temperature for 10 min. The resultant mixture was diluted to 0.047% of n-OG with 20 mM Tris-HCl (pH 8.0) and 
placed on ice for 30 min. This solution was used as proteoliposome.
ATPase assay. The reaction mixture (200 µl) for ATPase assay consisted of proteoliposome (0.1 µM 
Smon0121-Smon0122(10xHis)/Smon0120-Smon0120), 10 mM MgCl2, 2 mM ATP, 20 mM Tris-HCl (pH 
8.0), 1.5 µM Smon0123(N-18/C-0), and 0.1 mM each of various disaccharides. The reaction mixture without 
Smon0123 was incubated at 37 °C and reaction was started when Smon0123 was added. A portion of the reaction 
mixture (30 µl) was removed every 20 min during 0 to 80 min and added to 30 µl of 12% SDS to stop the reaction. 
After stopping reaction at 80 min, a mixture of 6% ascorbic acid/1 M HCl and 1% ammonium molybdate (60 µl) 
was added to the reaction solution (60 µl) and incubated at room temperature for 5 min. Subsequently, a mixture 
of 2% sodium citrate, 2% sodium metaarsenite, and 2% acetic acid (90 µl) was added to the solution and incu-
bated at 37 °C for 10 min38. This reaction mixture was measured in absorbance at 850 nm to determine phosphate 
ion concentration generated through ATP hydrolysis. ATPase activity was represented as phosphate ion (nmol) 
produced by 1 mg Smon0121-Smon0122(10xHis)/Smon0120-Smon0120 per 1 min. The value measured using 
proteoliposome and disaccharides was subtracted from that using liposomes without any proteins and ligands.
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